Literature DB >> 25198100

Routes to induced pluripotent stem cells.

Tyson Ruetz1, Keisuke Kaji2.   

Abstract

The generation of induced pluripotent stem cells (iPSCs) with Oct4, Sox2, Klf4, c-Myc has been described as 'direct' reprogramming in contrast to reprogramming via nuclear transfer. Interestingly, recent studies have suggested that the conversion process itself includes transient up-regulation and down-regulation of hundreds of genes, making unique intermediate populations. In a sense, the process of 4 factor reprogramming is indirect. Like in vitro differentiation, iPSC generation efficiency and kinetics largely depend on the external environment, as well as the amount and stoichiometry of exogenously expressed reprogramming factors. However, accumulating evidence indicates that when reprogramming succeeds, the process is not random but progresses in an ordered, step-wise manner. In this review, we summarize current knowledge detailing how somatic cells reach a pluripotent state.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25198100     DOI: 10.1016/j.gde.2014.08.006

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  6 in total

Review 1.  Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Karim Sallam; Yingxin Li; Philip T Sager; Steven R Houser; Joseph C Wu
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 2.  Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.

Authors:  Karamjit Singh Dolt; Fella Hammachi; Tilo Kunath
Journal:  Brain Pathol       Date:  2017-07       Impact factor: 6.508

3.  Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase.

Authors:  Akihiro Kuno; Ken Nishimura; Satoru Takahashi
Journal:  BMC Genomics       Date:  2018-01-03       Impact factor: 3.969

Review 4.  Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.

Authors:  Theo Stoddard-Bennett; Renee Reijo Pera
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

Review 5.  Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney.

Authors:  Letizia De Chiara; John Crean
Journal:  J Clin Med       Date:  2016-01-12       Impact factor: 4.241

6.  Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming.

Authors:  Ralph Stadhouders; Enrique Vidal; François Serra; Bruno Di Stefano; François Le Dily; Javier Quilez; Antonio Gomez; Samuel Collombet; Clara Berenguer; Yasmina Cuartero; Jochen Hecht; Guillaume J Filion; Miguel Beato; Marc A Marti-Renom; Thomas Graf
Journal:  Nat Genet       Date:  2018-01-15       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.